Premium
Q32 Bio Inc (QTTB)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1199 | -3.48546511628 | 3.44 | 4.1499 | 3.21 | 469273 | 3.66669037 | CS |
| 4 | -1.0299 | -23.675862069 | 4.35 | 4.41 | 3.02 | 617875 | 3.49638137 | CS |
| 12 | -46.2799 | -93.30625 | 49.6 | 53.17 | 3.02 | 363261 | 10.49421371 | CS |
| 26 | -16.6699 | -83.3911955978 | 19.99 | 53.79 | 3.02 | 221223 | 18.63215184 | CS |
| 52 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| 156 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| 260 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
